- Home
- CLPR vs LNSR Comparison
CLPR vs LNSR Comparison
Compare CLPR & LNSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLPR
- LNSR
- Stock Information
- Founded
- CLPR 2015
- LNSR 2004
- Country
- CLPR United States
- LNSR United States
- Employees
- CLPR N/A
- LNSR N/A
- Industry
- CLPR Real Estate Investment Trusts
- LNSR Medical Electronics
- Sector
- CLPR Real Estate
- LNSR Health Care
- Exchange
- CLPR Nasdaq
- LNSR Nasdaq
- Market Cap
- CLPR 72.0M
- LNSR 63.4M
- IPO Year
- CLPR 2017
- LNSR N/A
- Fundamental
- Price
- CLPR $4.41
- LNSR $14.60
- Analyst Decision
- CLPR Sell
- LNSR Strong Buy
- Analyst Count
- CLPR 2
- LNSR 1
- Target Price
- CLPR N/A
- LNSR $16.00
- AVG Volume (30 Days)
- CLPR 71.9K
- LNSR 127.4K
- Earning Date
- CLPR 05-06-2025
- LNSR 05-08-2025
- Dividend Yield
- CLPR 8.44%
- LNSR N/A
- EPS Growth
- CLPR N/A
- LNSR N/A
- EPS
- CLPR N/A
- LNSR N/A
- Revenue
- CLPR $148,775,000.00
- LNSR $53,494,000.00
- Revenue This Year
- CLPR N/A
- LNSR $29.95
- Revenue Next Year
- CLPR N/A
- LNSR $29.35
- P/E Ratio
- CLPR N/A
- LNSR N/A
- Revenue Growth
- CLPR 7.65
- LNSR 26.87
- 52 Week Low
- CLPR $3.38
- LNSR $2.67
- 52 Week High
- CLPR $7.12
- LNSR $16.40
- Technical
- Relative Strength Index (RSI)
- CLPR 49.90
- LNSR 61.21
- Support Level
- CLPR $4.21
- LNSR $12.71
- Resistance Level
- CLPR $4.61
- LNSR $16.40
- Average True Range (ATR)
- CLPR 0.23
- LNSR 1.87
- MACD
- CLPR -0.02
- LNSR 0.25
- Stochastic Oscillator
- CLPR 33.33
- LNSR 75.81
About CLPR Clipper Realty Inc.
Clipper Realty Inc is a self-administered and self-managed real estate company. It acquires, owns, manages, operates, and repositions multifamily residential and commercial properties in the New York metropolitan area, with a portfolio in Manhattan and Brooklyn. It has classified its reporting segments into Residential Rental Properties and Commercial Rental Properties. The company derives its revenue mostly from the Residential segment.
About LNSR LENSAR Inc.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency and reproducibility by providing imaging, simplified procedure planning, efficient design and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. The consumable portion of the system consists of a disposable patient interface device, or PID, kit and a procedure license. Each procedure on each system requires the use of a PID kit.